Market Place
Sourcing Support
Avinger Reports Q3 2024 Results
07 Nov 2024 //
ACCESSWIRE
Avinger to Announce Third Quarter 2024 Results on November 7, 2024
29 Oct 2024 //
ACCESSWIRE
Positive 12-Week Blood Sugar Results from Lexaria’s GLP-1 Study
24 Oct 2024 //
ACCESSWIRE
Avinger Announces New U.S. Patent And Five Allowances
18 Sep 2024 //
ACCESSWIRE
Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer
05 Aug 2024 //
ACCESSWIRE
Avinger to Announce Second Quarter 2024 Results on August 8, 2024
29 Jul 2024 //
ACCESSWIRE
Avinger Announces Closing Of Up To $24 Million Public Offering
17 Jun 2024 //
ACCESSWIRE
Avinger Announces Pricing of up to $24 Million Public Offering
14 Jun 2024 //
ACCESSWIRE
Avinger: Coronary Focus, Reduced Peripheral Business Costs
05 Jun 2024 //
ACCESSWIRE
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity
16 May 2024 //
ACCESSWIRE
Avinger Reports First Quarter 2024 Results
15 May 2024 //
ACCESSWIRE
Avinger to Announce First Quarter 2024 Results on May 15, 2024
07 May 2024 //
ACCESSWIRE
Avinger Reports Fourth Quarter and Full Year 2023 Results
20 Mar 2024 //
ACCESSWIRE
Avinger to Announce Full Year 2023 Results on March 20, 2024
12 Mar 2024 //
ACCESSWIRE
Avinger Announces Partnership with Zylox-Tonbridge
06 Mar 2024 //
ACCESSWIRE
Avinger Announces Strategic Partnership with Zylox-Tonbridge
06 Mar 2024 //
ACCESSWIRE
Avinger Reports Third Quarter 2023 Results
26 Oct 2023 //
ACCESSWIRE
Avinger to Announce Third Quarter 2023 Results on October 26
19 Oct 2023 //
ACCESSWIRE
Avinger Raises $5.3 Million via At-The-Market Facility
27 Sep 2023 //
ACCESSWIRE
Avinger Initiates Full Commercial Launch of CTO Crossing Device
18 Sep 2023 //
ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at AMP 2023
24 Aug 2023 //
ACCESSWIRE
Avinger Reports Second Quarter 2023 Results
27 Jul 2023 //
ACCESSWIRE
Avinger to Announce Second Quarter 2023 Results on July 27
20 Jul 2023 //
ACCESSWIRE
Avinger Announces First Cases with Tigereye ST Image-Guided CTO Crossing Device
05 Jun 2023 //
ACCESSWIRE
Avinger Reports Fourth Quarter 2022 Results
15 Mar 2023 //
ACCESSWIRE
Avinger to Announce Fourth Quarter 2022 Results on March 15
02 Mar 2023 //
ACCESSWIRE
Avinger Announces Issuance of Seven New Patents Expanding Coverage
04 Nov 2022 //
ACCESSWIRE
Avinger to Announce Third Quarter 2022 Results on November 9
01 Nov 2022 //
ACCESSWIRE
Avinger to Present at LD Micro Investor Conference
19 Oct 2022 //
ACCESSWIRE
Interim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022
01 Sep 2022 //
ACCESSWIRE
Avinger Closes $5M Registered Direct and Private Placement Offerings
08 Aug 2022 //
ACCESSWIRE
